New PET tracer aims to light up inflammation in joint and muscle diseases
NCT ID NCT03912428
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times
Summary
This early-phase study tested a new radioactive imaging drug called 11C-MC1 to see if it can help detect inflammation in people with rheumatoid arthritis or idiopathic inflammatory myopathy, as well as in healthy volunteers. Participants received PET/CT scans after an injection of the drug, and some also took celecoxib to see if it blocked the signal. The study was terminated early, so its findings are limited, but the goal was to develop a better way to visualize inflammation in the body.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 11C-MC1 (a radioactive imaging drug)
- What this could lead to
- If it works, this could lead to a better way to see inflammation in the body using PET scans, helping doctors diagnose and monitor conditions like arthritis and myositis.
- What could go wrong
- This was a very early (Phase 1) study that has already been terminated, so results are limited. The imaging drug is experimental and may not prove useful for routine diagnosis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AXIAL SPONDYLOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?